Premium
Intraoperative red cell salvage during obstetric surgery in 50 Japanese women
Author(s) -
Morikawa Mamoru,
Kuramoto Akitaka,
Nakayama Masaki,
Oguchi Hidenori,
Hasegawa Masaaki,
Funakoshi Toru,
Furukawa Seishi,
Hirayama Emi,
Kanagawa Takeshi,
Kaji Takashi,
Kasai Mayumi,
Konishi Yasuhiro,
Yamamoto Shinichi,
Itakura Atsuo,
Maeda Makoto,
Kobayashi Takao,
Minakami Hisanori
Publication year - 2015
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/j.ijgo.2014.09.008
Subject(s) - medicine , placenta previa , adverse effect , blood transfusion , surgery , obstetrics , obstetrics and gynaecology , retrospective cohort study , pregnancy , placenta , fetus , genetics , biology
Objective To determine the clinical usefulness of intraoperative cell salvage (ICS) in obstetrics. Methods A retrospective analysis was performed using data for 50 patients who had received ICS blood during obstetric surgery at 13 Japanese facilities between January 1, 2007 and December 31, 2013. The frequencies of ICS‐associated adverse events, allogeneic blood transfusion (ABT), and preoperative autologous donation (PAD) were assessed. Results Placenta previa was the indication for ICS in 42 (84%) women. The ICS blood was reinfused in all women (median 366 mL; range 80 to at least 3715). No ICS‐associated adverse events occurred. The median estimated blood loss (EBL) was 2171 mL (range 574–47 000); 27 (54%) women lost at least 2000 mL. ABT was not used in 33 (66%) women. Among 26 women who lost at least 2000 mL of blood and were included in analyses, 12 (44%) did not receive ABT. EBL was linearly correlated with the total volume of transfused blood ( P < 0.001). Conclusion ICS caused no adverse events among women at elevated risk of peripartum hemorrhage and might be safe for use in obstetrics.